HomeWSJ.com: World NewsPfizer Is Staking Its Turnaround on Cancer Drugs AdvanceNewsReader WSJ.com: World News Pfizer Is Staking Its Turnaround on Cancer Drugs Swarup Bhowmick August 19, 2024 0 Chris Boshoff, top oncology executive, counts on gains from the $43 billion Seagen merger. from WSJ.com: World News https://ift.tt/E7tYHpb Tags AdvanceNewsReader WSJ.com: World News Newer Older